NL-OMON22398招募中不适用
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis.
AMC Amsterdam0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 16
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Men/women suffering from rheumatoid arthritis, based on the American Rheumatism Association (ARA) 1987 criteria, who failed methotrexate treatment, will be eligible for the study;
- •2. Patients in ARA functional classes I, II, and III may be included.
排除标准
- •1. Pregnancy;
- •2. Breastfeeding;
研究者
相似试验
尚未招募
4 期
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritis10003816rheumatoid arthritisNL-OMON34549Academisch Medisch Centrum16
进行中（未招募）
不适用
Effects of abatacept (Orencia®) on biomarkers in synovial tissue in patients with rheumatoid arthritisrheumatoid arthritisEUCTR2010-021435-14-NLAcademisch Medisch Centrum Amsterdam
已完成
1 期
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers SquibbRheumatoid ArthritisNCT01439204Bristol-Myers Squibb223
已完成
不适用
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU CountriesRheumatoid ArthritisNCT02632890Bristol-Myers Squibb203
已完成
3 期
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateRheumatoid ArthritisNCT00048568Bristol-Myers Squibb1,250